Global Automated Breast Ultrasound Systems (ABUS) Market 2019-2023 | Evolving Opportunities With GE Healthcare and Hitachi, Ltd. | Technavio

Technavio has announced its latest market research report titled global automated breast ultrasound systems (ABUS) market 2019-2023 (Graphic: Business Wire)

LONDON--()--Technavio has been monitoring the global automated breast ultrasound systems (ABUS) market and the market is poised to grow by USD 422.74 million during 2019-2023 at a CAGR of more than 14% during the forecast period. Request Free Sample Pages

Read the 117-page research report with TOC on "Automated Breast Ultrasound Systems (ABUS) Market Analysis Report by End-users (Hospitals and clinics, and Diagnostic centers), by Geography (North America, Europe, ROW, and Asia), and Segment Forecasts, 2019 - 2023".

https://www.technavio.com/report/global-automated-breast-ultrasound-systems-abus-market-industry-analysis

The market is driven by the increasing demand for breast imaging products. In addition, the growing focus on development of integrated and innovative ABUS is anticipated to further boost the growth of the automated breast ultrasound systems (ABUS) market.

Exposure to post-menopausal hormone therapy, family history of breast cancer, ageing, radiation exposure, are some of the risk factors of developing breast cancer. The increasing number of breast cancer cases is boosting the demand for breast imaging products such as ABUS. ABUS is a non-invasive 3D ultrasound system that provides high efficacy in diagnostic results. In addition, it is recommended by many hospitals and clinics and diagnostic centers because it is radiation-free and painless. Thus, the increasing demand for non-invasive breast imaging products is expected to drive market growth during the forecast period.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Major Five Automated Breast Ultrasound Systems (ABUS) Market Companies:

GE Healthcare

GE Healthcare is headquartered in the US and operates the business under various segments such as Healthcare Systems and Life Sciences. The company offers Invenia ABUS 2.0.

Hitachi, Ltd.

Hitachi, Ltd. is headquartered in Japan and offers products through the following business units: Information & Telecommunication Systems, Social Infrastructure & Industrial Systems, Electronic Systems & Equipment, Construction Machinery, High Functional Materials & Components, Automotive Systems, and Smart Life & Ecofriendly Systems.

Koninklijke Philips N.V.

Koninklijke Philips N.V. is headquartered in the Netherlands and operates under various business segments, namely Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, and Other. The company offers Philips EPIQ and Affiniti ultrasound systems.

Siemens Healthineers AG

Siemens Healthineers AG is headquartered in Germany and offers products through the following business segments: Imaging, Diagnostics, and Advanced Therapies. The company offers ACUSON S2000 ABVS.

SonoCiné

SonoCiné is headquartered in the US and offers SonoCiné AWBUS. This product provides a consistent, repeatable scan of the whole breast to detect the presence of cancer cells.

Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform

Automated Breast Ultrasound Systems (ABUS) End-users Outlook (Revenue, USD Million, 2019 - 2023)

  • Hospitals and clinics
  • Diagnostic centers

Automated Breast Ultrasound Systems (ABUS) Regional Outlook (Revenue, USD Million, 2019 - 2023)

  • Asia
  • Europe
  • North America
  • ROW

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report

Related Reports on Health Care include:

Breast Cancer Therapeutics Market – Global Breast Cancer Therapeutics Market by product (targeted therapy, hormonal therapy, and chemotherapy) and geography (Americas, APAC, and EMEA).

Breast Biopsy Devices Market – Global Breast Biopsy Devices Market by product (biopsy needles and systems, biopsy image-guided systems, and others), modality (ultrasound-guided breast biopsy and MRI-guided breast biopsy), end-users (hospitals, ASCs, breast cancer specialty centers and clinics, and others) and geography (Asia, Europe, North America, and ROW).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: https://www.technavio.com

Release Summary

Global automated breast ultrasound systems (ABUS) market is poised to grow by USD 422.74 million during 2019-2023 at a CAGR of more than 14%.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: https://www.technavio.com